These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19416858)

  • 1. Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis.
    Yu Y; Lucitt MB; Stubbe J; Cheng Y; Friis UG; Hansen PB; Jensen BL; Smyth EM; FitzGerald GA
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7985-90. PubMed ID: 19416858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.
    Iwasa K; Yamamoto S; Takahashi M; Suzuki S; Yagishita S; Awaji T; Maruyama K; Yoshikawa K
    Prostaglandins Leukot Essent Fatty Acids; 2014 Nov; 91(5):175-82. PubMed ID: 25224839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of FP receptors in M1 macrophage polarization via IL-10-regulated nuclear translocation of NF-κB p65.
    Maehara T; Fujimori K
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158654. PubMed ID: 32036038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
    Wang M; Zukas AM; Hui Y; Ricciotti E; Puré E; FitzGerald GA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14507-12. PubMed ID: 16973753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element.
    Sales KJ; Grant V; Jabbour HN
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):51-61. PubMed ID: 18316157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin F2α facilitates collagen synthesis in cardiac fibroblasts via an F-prostanoid receptor/protein kinase C/Rho kinase pathway independent of transforming growth factor β1.
    Ding WY; Ti Y; Wang J; Wang ZH; Xie GL; Shang YY; Tang MX; Zhang Y; Zhang W; Zhong M
    Int J Biochem Cell Biol; 2012 Jun; 44(6):1031-9. PubMed ID: 22484488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin F(2alpha) receptor-dependent regulation of prostaglandin transport.
    Vezza R; Rokach J; FitzGerald GA
    Mol Pharmacol; 2001 Jun; 59(6):1506-13. PubMed ID: 11353812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.
    Errasti AE; del-Rey G; Cesio CE; Souza G; Nowak W; Pelorosso FG; Daray FM; Rothlin RP
    Eur J Pharmacol; 2009 May; 610(1-3):68-74. PubMed ID: 19289115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
    Zhou MS; Hernandez Schulman I; Pagano PJ; Jaimes EA; Raij L
    Hypertension; 2006 Jan; 47(1):81-6. PubMed ID: 16344366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
    Bhattacherjee P; Williams BS; Paterson CA
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential internalization of the prostaglandin f(2alpha) receptor isoforms: role of protein kinase C and clathrin.
    Srinivasan D; Fujino H; Regan JW
    J Pharmacol Exp Ther; 2002 Jul; 302(1):219-24. PubMed ID: 12065720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
    Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type I and prostaglandin F2α receptors cooperatively modulate signaling in vascular smooth muscle cells.
    Goupil E; Fillion D; Clément S; Luo X; Devost D; Sleno R; Pétrin D; Saragovi HU; Thorin É; Laporte SA; Hébert TE
    J Biol Chem; 2015 Jan; 290(5):3137-48. PubMed ID: 25512374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin F
    Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
    Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice.
    Ye J; Que B; Huang Y; Lin Y; Chen J; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Wang Z; Hu H; Xu Y; Shi L; Ye D; Liu J; Jiang H; Wan J; Ji Q
    Cardiovasc Res; 2019 May; 115(6):1102-1113. PubMed ID: 30395167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia.
    Takayama K; Yuhki K; Ono K; Fujino T; Hara A; Yamada T; Kuriyama S; Karibe H; Okada Y; Takahata O; Taniguchi T; Iijima T; Iwasaki H; Narumiya S; Ushikubi F
    Nat Med; 2005 May; 11(5):562-6. PubMed ID: 15834430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of prostaglandin F(2alpha) receptor isoforms by protein kinase C.
    Fujino H; Srinivasan D; Pierce KL; Regan JW
    Mol Pharmacol; 2000 Feb; 57(2):353-8. PubMed ID: 10648645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse.
    Tordjman KM; Semenkovich CF; Coleman T; Yudovich R; Bak S; Osher E; Vechoropoulos M; Stern N
    Hypertension; 2007 Nov; 50(5):945-51. PubMed ID: 17909121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.
    Griffin BW; Klimko P; Crider JY; Sharif NA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1278-84. PubMed ID: 10454504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.